Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Trying DAILIES TOTAL1 Multifocal Lenses in satisfied INFUSE wearers

Official title: Clinical Outcomes Following Refit From INFUSE One-Day Multifocal to DAILIES TOTAL1 Multifocal in Satisfied Presbyopic Wearers: A Prospective, Open-Label, Single-Arm Study

Run by Gordon Schanzlin New Vision · NCT07638943 · Data updated 2026-11-12

This study tests whether switching satisfied INFUSE One-Day Multifocal wearers to DAILIES TOTAL1 Multifocal lenses maintains comfort and clear vision.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment30 (estimated)
SponsorGordon Schanzlin New Vision
Academic / other
Locations1 site (La Jolla, California)
StatusRecruiting
StartedMay 20, 2026
Main results expectedJanuary 31, 2027
Study endsFebruary 28, 2027
Registry record updatedJune 11, 2026
Trial IDNCT07638943 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40 and older who are currently satisfied INFUSE One-Day Multifocal wearers, wear lenses at least 8 hours daily, and have mild dry-eye symptoms but good overall vision.

Probably not a fit

Patients with active ocular infection, inflammation, severe dry eye, or uncontrolled systemic conditions may not benefit from this refitting approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines comfort and vision when refitting experienced INFUSE One-Day Multifocal wearers with DAILIES TOTAL1 Multifocal lenses. Eligible participants are 40 years and older who currently wear INFUSE multifocal lenses and meet daily-wear and dry-eye criteria. The study focuses on lens materials that support a healthy tear film and stable optical performance over extended wear. Participants will wear the DAILIES TOTAL1 Multifocal lenses for at least 8 hours per day, five days a week, and complete study questionnaires to assess comfort and vision outcomes. The approach aims to determine if a high-oxygen water-gradient or osmoprotective lens design can sustain physiological comfort without compromising visual clarity.

Why it matters

Potential benefit: If successful, participants may experience improved all-day comfort and stable near-to-distance vision with a lens that better supports the tear film.

How similar studies have gone: Prior multifocal lens work has shown variable comfort with refitting; this study explores a newer lens material in a specific prior-wear population, generating novel data for this niche group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age ≥40 years at enrollment Current satisfied wearer of Bausch + Lomb INFUSE One-Day Multifocal (kalifilcon A) in both eyes; Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) score \<12 at baseline Minimum contact lens wear of ≥8 hours/day, ≥5 days/week, for ≥30 days prior to Visit 1 Best-corrected distance visual acuity ≥20/25 (0.18 LogMAR) or better in each eye Manifest refraction within study lens parameters (Sphere: +6.00 D to -10.00 D; Add: Low, Medium, High) Willing to wear DAILIES TOTAL1 Multifocal lenses for ≥8 hours/day, ≥5 days/week and complete all study questionnaires Able to provide written informed consent and comply with investigator instructions

Exclusion Criteria:

Active ocular infection, inflammation, or clinically significant ocular surface disease (e.g., severe dry eye, pterygium, keratoconus) Uncontrolled systemic disease or use of systemic medications known to significantly affect the tear film, unless on a stable dose for ≥90 days History of refractive surgery (LASIK, PRK, RK) or intraocular surgery (cataract or IOL implantation) Clinically significant ectropion, entropion, or trichiasis Baseline corneal fluorescein staining score \>2 in any single zone (NEI/Industry scale) Current monovision or modified monovision contact lens wear Pregnant or lactating participants Participation in another clinical trial within 30 days prior to enrollment

Where it's running

  • Gordon Schanzlin New Vision Institute
    La Jolla, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.